In fact, it has been shown that RANKL, the molecule able to induce osteoclast differentiation, can also increase the levels and activity of the hyperglycemic enzyme DPPIV [231], which is able to cleave the hormone GLP-1, leading to insulin resistance development and hyperglycemia (Figure 3). The gene discussed is GLP1R; the disease is Insulin resistance.